HUT67813A - 2-hydroxy-3-[1-(1h-imidazol-4-yl)-alkyl]-benzenecarboxamidines and pharmaceutical compositions containing them - Google Patents

2-hydroxy-3-[1-(1h-imidazol-4-yl)-alkyl]-benzenecarboxamidines and pharmaceutical compositions containing them Download PDF

Info

Publication number
HUT67813A
HUT67813A HU9401574A HU9401574A HUT67813A HU T67813 A HUT67813 A HU T67813A HU 9401574 A HU9401574 A HU 9401574A HU 9401574 A HU9401574 A HU 9401574A HU T67813 A HUT67813 A HU T67813A
Authority
HU
Hungary
Prior art keywords
hydroxy
imidazol
alkyl
formula
compound
Prior art date
Application number
HU9401574A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9401574D0 (en
Inventor
Eric Cossement
Jean Gobert
Ernst Wuelfert
Philippe Michel
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of HU9401574D0 publication Critical patent/HU9401574D0/hu
Publication of HUT67813A publication Critical patent/HUT67813A/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU9401574A 1993-05-27 1994-05-25 2-hydroxy-3-[1-(1h-imidazol-4-yl)-alkyl]-benzenecarboxamidines and pharmaceutical compositions containing them HUT67813A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310965A GB9310965D0 (en) 1993-05-27 1993-05-27 2-hydroxy-3-(1h-imidazol-4-yl)alkyl)benzenecarboximidamides

Publications (2)

Publication Number Publication Date
HU9401574D0 HU9401574D0 (en) 1994-08-29
HUT67813A true HUT67813A (en) 1995-05-29

Family

ID=10736226

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9401574A HUT67813A (en) 1993-05-27 1994-05-25 2-hydroxy-3-[1-(1h-imidazol-4-yl)-alkyl]-benzenecarboxamidines and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US5385927A (https=)
EP (1) EP0626372B1 (https=)
JP (1) JPH0770082A (https=)
AT (1) ATE198196T1 (https=)
AU (1) AU673422B2 (https=)
CA (1) CA2124289A1 (https=)
CZ (1) CZ287136B6 (https=)
DE (1) DE69426433D1 (https=)
FI (1) FI942390L (https=)
GB (1) GB9310965D0 (https=)
HU (1) HUT67813A (https=)
IL (1) IL109750A (https=)
MY (1) MY111216A (https=)
NO (1) NO303824B1 (https=)
NZ (1) NZ260588A (https=)
PL (1) PL175970B1 (https=)
RU (1) RU2125557C1 (https=)
SG (1) SG42791A1 (https=)
SK (1) SK60394A3 (https=)
TW (1) TW263500B (https=)
ZA (1) ZA943651B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
US6200967B1 (en) 1996-06-25 2001-03-13 Eli Lilly And Company Anticoagulant agents
CA2258915A1 (en) * 1996-06-25 1997-12-31 Michael Robert Wiley Anticoagulant agents
PL360707A1 (en) * 2000-07-14 2004-09-20 Allergan Inc. Compositions containing alpha-2-adrenergic agonist components
US7902247B2 (en) * 2008-01-09 2011-03-08 Allergan, Inc. Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
EP2196461A1 (de) 2008-12-15 2010-06-16 Bayer CropScience AG 4-Amino-1,2,3-benzoxathiazin-Derivate als Pestizide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8626287D0 (en) * 1986-11-04 1986-12-03 Ucb Sa Substituted 1h-imidazoles
GB8810067D0 (en) * 1988-04-28 1988-06-02 Ucb Sa Substituted 1-(1h-imidazol-4-yl)alkyl-benzamides
FI98815C (fi) * 1990-11-30 1997-08-25 Santen Oy Menetelmä uusien, farmakologisesti käyttökelpoisten bispilokarpiinihapon esterijohdannaisten valmistamiseksi

Also Published As

Publication number Publication date
TW263500B (https=) 1995-11-21
PL175970B1 (pl) 1999-03-31
ZA943651B (en) 1995-01-26
US5385927A (en) 1995-01-31
RU2125557C1 (ru) 1999-01-27
EP0626372B1 (fr) 2000-12-20
MY111216A (en) 1999-09-30
NO941932D0 (no) 1994-05-25
CZ287136B6 (en) 2000-09-13
JPH0770082A (ja) 1995-03-14
IL109750A0 (en) 1994-08-26
NO941932L (no) 1994-11-28
DE69426433D1 (de) 2001-01-25
CA2124289A1 (en) 1994-11-28
NO303824B1 (no) 1998-09-07
AU6330394A (en) 1994-12-01
FI942390A7 (fi) 1994-11-28
EP0626372A1 (fr) 1994-11-30
IL109750A (en) 1998-06-15
FI942390L (fi) 1994-11-28
NZ260588A (en) 1995-09-26
SG42791A1 (en) 1997-10-17
AU673422B2 (en) 1996-11-07
CZ124794A3 (en) 1994-12-15
FI942390A0 (fi) 1994-05-24
SK60394A3 (en) 1995-07-11
ATE198196T1 (de) 2001-01-15
HU9401574D0 (en) 1994-08-29
GB9310965D0 (en) 1993-07-14

Similar Documents

Publication Publication Date Title
DE69532561T2 (de) Neue Aminosäurederivate mit verbesserter Multi-Drug-Resistenz-Aktivität
CN116583281A (zh) Jak抑制剂的结晶多晶型物形式a及用于其的制备的方法
CN103200941B (zh) 用于降低眼内压的[3-(1-(1h-咪唑-4-基)乙基)-2-甲基苯基]甲醇的酯前药
DE60035039T2 (de) Renin-inhibitoren
DE69916586T2 (de) Indol-derivate und medizinische zusammensetzungen die diese enthalten
DE69004973T2 (de) Piperidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel.
DE69007471T2 (de) Verfahren zur verhütung oder zur begrenzung einer reperfusionsschädigung.
JPH0372467A (ja) ピペラジン誘導体
DE69200284T2 (de) Verwendung von 4-(3-trifluormethylphenyl)-1,2,3,6-Tetrahydropyridinderivaten als freie Radikalfänger.
HUT67813A (en) 2-hydroxy-3-[1-(1h-imidazol-4-yl)-alkyl]-benzenecarboxamidines and pharmaceutical compositions containing them
HU190648B (en) Process for preparing n-substituted 2,3,4,5-tetra-hydro-1h-3-benzazepine derivatives
EP0222283B1 (de) Aminosäurederivate
JPH08507303A (ja) 非競合的nmda受容体アンタゴニストとしての2h−1,2,4−ベンゾチアジアジン3(4h)−オン1,1ジオキシド誘導体の使用
DE69011602T2 (de) Substituierte 4-Aminochinoline.
JPH07119189B2 (ja) 光学活性なベンジルアルコール誘導体及びその用途
AU723563B2 (en) Use of a combination of delavirdine and one or more protease inhibitors in HIV-1 infected patients
JP2003503476A (ja) 環化アミド誘導体
DE69707080T2 (de) Pyrrolidinonderivate und ihre Verwendung als antipsychotische Arzneimittel
SU791241A3 (ru) Способ получени производных 4,5,6,7-тетрагидроимидазо 4,5-с пиридина
DE69528288T2 (de) Indolderivate zur behandlung von migräne
EP1315729A1 (en) Compounds in the form of homodimeric, heterodimeric and/or homo and heteromultimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterasis-mediated diseases or dysfunction
EP0710482B1 (en) Therapeutic agent for myocardial ischemic damages or reperfusion injuries
DE68909961T2 (de) 2-Aminoacetamid Derivate.
EP1757601B1 (en) Quinoline derivatives and their use in glaucoma and myopia
WO2006088080A1 (ja) シクロヘプタ[b]ピリジン-3-カルボニルグアニジン誘導体およびそれを含有する医薬品

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee